Li Xiumin

Li Xiumin


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2009 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
LXLi Xiumin
Li Xiumin
LBLaVerne Brown
LaVerne Brown

15 March 2003 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
LXLi Xiumin
Li Xiumin
KSKamal Srivastava
Kamal Srivastava
JHJames W. Huleatt
James W. Huleatt
KBKim Bottomly
Kim Bottomly
ABA. Wesley Burks
A. Wesley Burks
HSHugh A Sampson
Hugh A Sampson
Peanut allergy (PNA) is the major cause of fatal and near-fatal anaphylactic reactions to foods. Traditional immunotherapy using peanut (PN) protein is not an option for PNA therapy because of the high incidence of adverse reactions. We investigated the effects of s.c. injections of engineered (modified) recombinant PN proteins and heat-killed Listeria monocytogenes (HKLM) as an adjuvant on anaphylactic reactions in a mouse model of PN allergy. PN-allergic C3H/HeJ mice were treated s.c. with a mixture of the three major PN allergens and HKLM (modified (m)Ara h 1–3 plus HKLM). The effects on anaphylactic reactions following PN challenge and the association with Ab levels and cytokine profiles were determined. Although all mice in the sham-treated groups exhibited anaphylactic symptoms with a median symptom score of 3, only 31% of mice in the mAra h 1–3 plus HKLM group developed mild anaphylaxis, with a low median symptom score of 0.5. Alterations in core body temperature, bronchial constriction, plasma histamine, and PN-specific IgE levels were all significantly reduced. This protective effect was markedly more potent than in the mAra h 1–3 protein alone-treated group. HKLM alone did not have any protective effect. Reduced IL-5 and IL-13, and increased IFN-γ levels were observed only in splenocytes cultures from mAra h 1–3 plus HKLM-treated mice. These results show that immunotherapy with modified PN proteins and HKLM is effective for treating PN allergy in this model, and may be a potential approach for treating PNA.

8 January 2009 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
BJBolleddula Jayaprakasam
Bolleddula Jayaprakasam
SDSrinivasulu Doddaga
Srinivasulu Doddaga
RWRong Wang
Rong Wang
DHDaniel Holmes
Daniel Holmes
JGJoseph Goldfarb
Joseph Goldfarb
LXLi Xiumin
Li Xiumin

1 April 2015 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
YSYing Song
Ying Song
JWJulie Wang
Julie Wang
NLNicole Leung
Nicole Leung
LWLi Xin Wang
Li Xin Wang
LLLauren Lisann
Lauren Lisann
LXLi Xiumin
Li Xiumin

1 October 2015 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
JWJulie Wang
Julie Wang
SJStacie M. Jones
Stacie M. Jones
JPJacqueline A. Pongracic
Jacqueline A. Pongracic
YSYing Song
Ying Song
NYNan Yang
Nan Yang
LXLi Xiumin
Li Xiumin

19 November 2012 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
NYNan Yang
Nan Yang
SPSangita Patil
Sangita Patil
JZJian Zhuge
Jian Zhuge
MWMing‐Chun Wen
Ming‐Chun Wen
JBJayaprakasam Bolleddula
Jayaprakasam Bolleddula
LXLi Xiumin
Li Xiumin